SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?

To: gy who wrote (1063)7/15/1998 9:18:00 AM
From: David Cathcart  Respond to of 1826
 
gy,

I agree with you about the good news. The following quote from Blitzer is, IMO, very significant, "We also observed additional evidence of antitumor activity in some patients, leading us to remain very optimistic about the potential of this compound."

I'll be anxious to hear more of the specifics. This bodes well heading into phase II this month and, perhaps, for the likelihood of the European partner becoming a reality.

David


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News